Comunicati Stampa
Economia

Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands

New Alira Health Report Reveals Digital and Sustainable Innovations Driving Drug Delivery Market Key Market Drivers and Trends Digitalization, Sustainability, and Patient CentricityDDS providers are embedding digital features and co-developing devices with patients to improve adherence tracking, generate real-world evidence, and enhance usability in diabetes, GLP-1 therapies, and rare chronic diseases. Sustainability is becoming a critical priority, with reusable injectors,...
FRAMINGHAM, (informazione.news - comunicati stampa - economia)

Key Market Drivers and Trends

"This report underscores that drug delivery innovation today is about more than devices – it’s about integrating digital capabilities, patient-centered design, sustainability, and manufacturing to transform pharma partnerships and accelerate patient access," said Gabriele Brambilla, CEO of Alira Health and Chair of its DDS Center of Excellence. "By examining trends across the DDS value chain, it offers industry stakeholders a comprehensive guide to navigating a rapidly evolving ecosystem."

The 2025 Global Drug Delivery System Trends Report offers detailed market analysis and thought leadership insights on how to address strategic questions, arming pharmaceutical companies, device manufacturers, CDMOs, and investors with actionable intelligence to stay competitive in this dynamic and fast-growing sector. The report is released in partnership with PODD: Partnership Opportunities in Drug Delivery.

The 2025 Global Drug Delivery System Trends Report is available to read here.

About Alira Health

Alira Health is a global healthcare consultancy that partners with life sciences companies to deliver patient-centered solutions. We generate and apply evidence across the product lifecycle through four integrated capabilities: CRO services, consulting, patient engagement training, and technology. Our approach helps clients improve access, adoption, and impact, guided by the voice of the patient. To learn more about Alira Health, please visit alirahealth.com.



Per maggiori informazioni
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili